EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat?

Aleksandra Zoń iD, Ilona Anna Bednarek iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27104205 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Aleksandra Zoń und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-2…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Autophagy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite extensive research, the treatment of ovarian cancer remains a significant challenge. One promising strategy involves the regulation of autophagy in cancer cells. However, this process is exceptionally complex and, depending on numerous factors, it can either suppress tumor progression, by maintaining genomic stability and limiting inflammatory responses, or exert a pro-tumor effect, enabling cancer cells to survive in unfavorable environmental conditions. Furthermore, the activation of this pathway can contribute to the development of resistance to drugs used in ovarian cancer therapy, such as cisplatin or paclitaxel. Current therapeutic approaches focus on both the induction and inhibition of autophagy, primarily by targeting the two most important pathways regulating this process: PI3K/Akt/mTOR and AMPK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAutophagyHumansFemaleDrug Resistance, NeoplasmSignal TransductionAnimalsAntineoplastic AgentsPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesCisplatinProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

autophagychemoresistancecisplatin resistanceovarian cancer

Substanzen

Antineoplastic AgentsPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesCisplatinProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Biotechnology and Genetic Engineering, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland.

ORCID-Profile: Aleksandra Zoń, Ilona Anna Bednarek

Förderung

  • Medical University of Silesia

Zitieren

APA

Zoń, A., & Bednarek, I. A. (2026). Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104205

Vancouver

Zoń A, Bednarek IA. Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat?. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104205

BibTeX
@article{Zo2026,
  author = {Zoń, Aleksandra and Bednarek, Ilona Anna},
  title = {Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat?},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27104205}
}
Kostenlos starten →